Target intelligence / Profile preview

Transforming growth factor beta receptor 1 (TGFBR1)

Target
TGFBR1
Molecular classification
Receptor, Serine/threonine protein kinase, Transmembrane receptor
01

Overview

Transforming growth factor beta receptor 1 (TGFBR1) is a membrane-bound serine/threonine protein kinase that forms part of the TGF-β receptor complex. It functions as a critical component in the TGF-β signaling pathway, which regulates numerous cellular processes including proliferation, differentiation, motility, adhesion, and apoptosis. When TGF-β ligand binds to the type II receptor (TGFBR2), TGFBR1 is recruited to form a heteromeric complex. The constitutively active TGFBR2 then phosphorylates and activates TGFBR1, which in turn phosphorylates downstream SMAD proteins (primarily SMAD2 and SMAD3). These phosphorylated SMADs associate with SMAD4 and translocate to the nucleus where they regulate gene expression. TGFBR1 is involved in both canonical (SMAD-dependent) and non-canonical (SMAD-independent) signaling pathways. Mutations in the TGFBR1 gene have been associated with Loeys-Dietz aortic aneurysm syndrome. Animal studies have shown that TGFBR1 plays a critical role in female reproductive tract function, with knockout mice exhibiting infertility and abnormal uterine development. Several inhibitors targeting TGFBR1 have been developed, including GW-788388, LY-2109761, Galunisertib, SB-431542, and SB-525334, which may have therapeutic potential in conditions where TGF-β signaling is dysregulated, such as fibrosis and certain cancers.

Other names
TGF-beta receptor type-1Activin A receptor type II-like kinase (53kDa)ALK5TGFR1
02

Mechanism of action

TGFBR1 functions through both canonical (SMAD-dependent) and non-canonical (SMAD-independent) pathways. Canonical pathway: 1. TGF-β binds to TGF-β type II receptor (TGFBR2) 2. TGFBR2 recruits TGFBR1 into a heteromeric complex 3. TGFBR1 is phosphorylated by the constitutively active TGFBR2 4. Activated TGFBR1 phosphorylates SMAD2/3 5. Phosphorylated SMAD2/3 associates with SMAD4 6. The SMAD complex translocates to the nucleus 7. The complex regulates transcription of TGF-β-regulated genes. Non-canonical pathway: - Induces TRAF6 autoubiquitination leading to MAP3K7 ubiquitination and activation to trigger apoptosis - Regulates epithelial to mesenchymal transition through PARD6A phosphorylation and activation.

03

Biological functions

Signal transductionCell proliferation and differentiationEmbryonic developmentAngiogenesisWound healingEpithelial to mesenchymal transitionApoptosisFemale reproductive tract function
04

Disease associations

Cancer (both tumor suppression and promotion)Loeys-Dietz aortic aneurysm syndrome (LDAS)Fertility issuesFibrosis
05

Safety considerations

Targeting TGFBR1 may have context-dependent effects due to its dual role in cancer (both tumor suppressive and promoting)Potential reproductive side effects, particularly in females, based on animal studies showing fertility issues when TGFBR1 is knocked outPotential developmental effects as TGFBR1 plays important roles in embryonic development
06

Interacting drugs

GW-788388

6 more in the full profile.

07

Biomarkers

Phosphorylated SMAD2/3 levelsTGFBR1 expression levels

Beyond the preview

Go deeper on Transforming growth factor beta receptor 1 (TGFBR1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transforming growth factor beta receptor 1 (TGFBR1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call